Fibrate therapy may lower the risks of mortality and progression to end-stage kidney disease (ESKD), despite raising the risk for new onset stage 3 or higher chronic kidney disease (CKD), a new study ...

There may be “substantial delays” between when a drug is granted accelerated approval for a cancer indication, when negative trial results are released, and when the accelerated approval of the drug ...

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

Prevalence of smoking continued to drop during pandemic, but prevalence of excess body weight, HPV vaccination remained stable.

(HealthDay News) — The prevalence of depression among adolescents and adults aged 12 years and older during August 2021 to August 2023 was 13.1 percent, a 60 percent increase from 2013-2014, according ...

The FDA warning is about a topical spray version of finasteride, a drug often sold online by telehealth companies like Hims, Keeps and Ro, The Wall Street Journal reported. While the pill form of ...

Residual nodal disease following neoadjuvant chemotherapy for upper tract urothelial carcinoma (UTUC) indicates an especially high-risk population.

(HealthDay News) — Average and brisk walking pace are associated with a decreased risk for cardiac arrhythmias, according to a study published online April 15 in Heart.

Rates of neutropenia, lymphopenia, and infections were lower in the patients receiving avacopan than those who were not.

There are currently no proven therapies that reduce cisplatin-induced acute kidney injury (AKI) in patients with cancer.

Though 45% of patients said they could see the benefits of AI in health care, 44% said the idea of AI in health care settings scares them.

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.